Ischemia-modified albumin in gynecology
Journal: 2021/March - Biomarkers in Medicine
Abstract:
Background: Ischemia-modified albumin (IMA) is an oxidative stress marker used to assess the presence and severity of oxidative stress. This marker was first used for early diagnosis of myocardial ischemia. Materials & methods: A variety of IMA studies were carried out to show the effect of oxidative stress on gynecological disorders. Conclusion: This analysis summarizes the literature by conducting electronic research on the relationship between IMA and gynecological disorders.
Keywords: IVF; PCOS; endometriosis; gynecology; ischemia-modified albumin; menopause; oxidative stress.
Relations:
Citations
(1)
Diseases
(2)
Conditions
(1)
Processes
(2)
Similar articles
Articles by the same authors
Discussion board
Collaboration tool especially designed for Life Science professionals.Drag-and-drop any entity to your messages.